Feasibility Study of Developing a Saline-Based Antiviral Nanoformulation Containing Lipid-Soluble EGCG: A Potential Nasal Drug to Treat Long COVID
Abstract
Share and Cite
Frank, N.; Dickinson, D.; Garcia, W.; Liu, Y.; Yu, H.; Cai, J.; Patel, S.; Yao, B.; Jiang, X.; Hsu, S. Feasibility Study of Developing a Saline-Based Antiviral Nanoformulation Containing Lipid-Soluble EGCG: A Potential Nasal Drug to Treat Long COVID. Viruses 2024, 16, 196. https://doi.org/10.3390/v16020196
Frank N, Dickinson D, Garcia W, Liu Y, Yu H, Cai J, Patel S, Yao B, Jiang X, Hsu S. Feasibility Study of Developing a Saline-Based Antiviral Nanoformulation Containing Lipid-Soluble EGCG: A Potential Nasal Drug to Treat Long COVID. Viruses. 2024; 16(2):196. https://doi.org/10.3390/v16020196
Chicago/Turabian StyleFrank, Nicolette, Douglas Dickinson, William Garcia, Yutao Liu, Hongfang Yu, Jingwen Cai, Sahaj Patel, Bo Yao, Xiaocui Jiang, and Stephen Hsu. 2024. "Feasibility Study of Developing a Saline-Based Antiviral Nanoformulation Containing Lipid-Soluble EGCG: A Potential Nasal Drug to Treat Long COVID" Viruses 16, no. 2: 196. https://doi.org/10.3390/v16020196
APA StyleFrank, N., Dickinson, D., Garcia, W., Liu, Y., Yu, H., Cai, J., Patel, S., Yao, B., Jiang, X., & Hsu, S. (2024). Feasibility Study of Developing a Saline-Based Antiviral Nanoformulation Containing Lipid-Soluble EGCG: A Potential Nasal Drug to Treat Long COVID. Viruses, 16(2), 196. https://doi.org/10.3390/v16020196